Delivery Order SPE2DB22D2214-SPE2DB25FS2SB

Award Date 11/6/24
Potential Completion Date 11/7/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS2SB
    Delivery Order

This federal contract award, valued at $14,782.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026.

The contract covers the delivery of GILENYA 0.5 MG CAPSULE 30S, a prescription medication, to support federal healthcare programs. The award has a firm-fixed price pricing type and an ultimate completion date of November 7, 2024. No set-aside requirements were specified for this contract. Amerisourcebergen's extensive experience in supplying pharmaceutical products and medical supplies to various federal agencies, including the DLA and the Department of Justice Federal Bureau of Investigation, makes the company well-suited to fulfill this contract and support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/5/25, 9:24 AM